Stay updated on IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 was added and the earlier funding-status notice (v3.4.1) was removed; these are administrative site updates that do not affect the trial details or displayed study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:27:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Notice added about government funding and operating status; site version updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated footer metadata with 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older 'Last Update Submitted that met QC Criteria' label, 'No FEAR Act data', and 'Revision: v3.3.4' from the page.
    Difference
    0.2%
    Check dated 2026-01-28T03:51:54.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed, reflecting a minor site version update. This update does not affect study details or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:28:26.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations section updated to include Georgia, Ohio, and Wisconsin. HHS Vulnerability Disclosure and related location headings were removed; the page revision now shows v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T08:38:11.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updated from v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:32:37.000Z thumbnail image

Stay in the know with updates to IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.